Skip to main content
. 2022 Nov 11;24(Suppl H):H48–H56. doi: 10.1093/eurheartjsupp/suac059

Figure 6.

Figure 6

Incidence of MACE at 24 months follow-up according to diagnostic assessments (A) and personalized therapy (B). Angio, coronary angiography; ACH, acetylcholine provocation test; FFR, fractional flow reserve assessment; CCB, calcium-channel blockers; BB, beta-blockers.